This concept was again supported in the present work by our interrogation of a large public colon cancer database which confirmed that while CHRM3 levels were significantly elevated in cancer compared to those in normal colon tissue, CHRM1 levels were modestly, but significantly, reduced in cancer. Here, CHRM3 is linked to malignant colon neoplasm.